PharmStars’ Spring 2024 cohort will focus on startups with digital innovations in oncology. We welcome applications from startups with any type of cancer-related digital health solution, including innovations that pharma can leverage in drug development, clinical trials, or drug delivery, as well as cancer-related tools that can be used by providers and/or patients.
All digital health startups with an interest in partnering with pharma are welcome to apply. For our first cohort, priority will be given to startups with innovative digital health solutions that enhance and improve any aspect of clinical trials. Additional details can be found here.
Dear applicant, we have been notified of some technical issues with our application form provider. Though it seems to be a rare occurrence, please make a record of your responses prior to submission ("print page" and save page as a PDF document).
If you encounter a problem submitting your form using the submit button below, please email your PDF submission to info@pharmstars.com.
All digital health startups with an interest in partnering with pharma are welcome to apply. For our first cohort, priority will be given to startups with innovative digital health solutions that enhance and improve any aspect of clinical trials. Additional details can be found here.